Atara Biotherapeutics, Inc.
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical…
Biotechnology
US, South San Francisco [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Atara Biotherapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Atara Biotherapeutics, Inc. has no acquisition track records yet.